An interventional study of 12 weeks of High-intensity Interval Training and 12 weeks of Moderate-Intensity Continuous Training in Stroke, sponsored by McGill University. Recruiting at 2 sites in Canada. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-10-19.
Sponsored by McGill University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Stroke by McGill University — 7 open to participants now, 7 under way, none of them phase 3. Stroke · McGill University.
Among the 16 studies in Stroke by McGill University, this one is the 3rd largest by planned enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2020, is one of 15 with no phase, and was the 4th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →7 of the 16 studies in Stroke by McGill University are open now, in 1 country. Recruiting first, the newest first:
McGill University · Sites in Canada
Ages 40–80
McGill University · Sites in Canada
Ages 40–84
McGill University · Sites in Canada
Ages 40–74
McGill University · Sites in Canada
Ages 18–85
McGill University · Sites in Canada
Ages 40–74
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 40 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 3 started in 2020.
This study's planned enrollment of 80 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 40 across the 15 interventional studies, 12 across the 1 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
McGill University is the lead sponsor of 249 studies on the registry; 50 are open to participants now.
4 of the studies in Stroke by McGill University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07201974McGill UniversityVirtual Reality for Post-Stroke Gait Rehabilitation | 2026-11 |
| NCT06621771McGill UniversityPlaying Piano to Improve Hand Function Early After Stroke | 2027-05-01 |
| NCT04559373McGill UniversityVirtual Reality and Field Training to Enhance Community Walking After Stroke | 2027-05-31 |
| NCT07178535McGill UniversityFeasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke | 2027-07-15 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Stroke by McGill University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main objective of this multi-site project is to compare the effects of 12 weeks of HIIT vs. MICT on brain plasticity. The effects of HIIT vs. MICT on cardiovascular health, psychosocial predictors of physical activity and motor function will also be compared. HIIT and MICT will be delivered through a whole-body exercise paradigm using a recumbent stepper that requires arm and leg forces. Outcomes will be assessed at baseline (T0, 0 weeks), at the end of the intervention (T1, 12 weeks) and at 8-week follow-up (T2, 20 weeks).
Background: Stroke is a major health issue in Canada, with 405,000 Canadians currently living with stroke. Exercise is an important component of stroke rehabilitation that can result in improved function and health. Traditionally, exercise rehabilitation programs for stroke employ moderate-intensity continuous training (MICT) protocols that are typically sustained for 20-30 minutes. The continuous nature of this form of training however, even at moderate intensities, is challenging for many individuals with stroke to sustain due to neuromotor impairments and poor exercise capacity. High-intensity exercise, when delivered in short interval bursts (i.e. high-intensity interval training, HIIT), may be a feasible alternative that allows higher intensities to be achieved during exercise. This is important because intensity of training is the critical factor in promoting changes in neuroplasticity and cardiovascular health, the two most important aspects of recovery and secondary prevention after stroke. Interventions implemented earlier following stroke are generally viewed to yield greater benefits, but high intensity exercise may also promote neuroplasticity and optimize cardiovascular health in later stages of recovery. Furthermore, determining if HIIT is viewed to be motivating and enjoyable for individuals post-stroke can provide insight into the sustainability of this intervention.
Objective: To compare the effects of 12 weeks of HIIT and MICT on neuroplasticity, cardiovascular health and psychosocial predictors of physical activity in individuals with chronic stroke.
Design: Participants will be recruited from two research sites and randomly allocated into HIIT or MICT. Participants will be assessed before and after the training period, and at an 8-week follow-up.
Outcomes: 1) The investigators will assess: Neuroplasticity: by measuring markers of corticospinal excitability at rest and in response to a non-invasive brain stimulation protocol applied over the primary motor cortex (M1); 2) Cardiovascular health: by measuring cardiorespiratory fitness, resting blood pressure, arterial stiffness, and waist-hip ratio; 3) Psychosocial predictors of physical activity: by measuring exercise motivation and enjoyment.
Methods: Neuroplasticity: motor evoked potentials amplitude, intracortical facilitation and short-intracortical inhibition on the lesioned and unlesioned upper limb M1 area at rest and in response to continuous theta-burst will be measured with transcranial magnetic stimulation; Cardiovascular health: cardiorespiratory fitness will be measured with a graded exercise test, resting blood pressure with an automated blood pressure monitor and arterial stiffness using applanation tonometry. Exercise motivation and enjoyment will be assessed with the Physical Activity Enjoyment Scale and the Behavioral Regulation Exercise Questionnaire-3, respectively.
Expected results: Both HIIT and MICT will result in improvements in outcomes of neuroplasticity and cardiovascular health. However, improvements with HIIT will be greater and will last longer. Participants will rate HIIT as enjoyable as MICT, and motivation for exercise will increase similarly after both interventions.
Impact: HIIT is a promising, time-efficient, and potentially more effective alternative to traditional MICT protocols that could offer an opportunity for greater improvement in motor recovery and cardiovascular health in people living with stroke.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intensity will be determined using a combination of heart rate reserve (HRR, calculated as HRR= \[max HR - resting HR\] x \[% training\] + \[resting HR\]) and ratings of perceived exertion (RPE). The protocol will involve 10 60-second intervals of high intensity interspersed with 9 60-second low-intensity intervals. The initial high intensity intervals will start at 80% of the HRR (RPE=14-17) and progress by 10% every 4 weeks. Low intensity intervals will be performed at 30% of HRR (RPE=9-11). Three-minute warm-up and 2-minute cool-down periods will be performed at 30% of HRR. Total HIIT time including warm-up and cool-down is 24 minutes.
Behavioral: 12 weeks of High-intensity Interval Training
Intensity will be determined using a combination of heart rate reserve (HRR, calculated as HRR= \[max HR - resting HR\] x \[% training\] + \[resting HR\]) and ratings of perceived exertion (RPE). The MICT protocol will be increased using a progression schedule previously used (initial intensity at 40% HRR (RPE=9-11), and progressed by 10% HRR every 4 weeks up to 60% HRR (RPE=13-14) will be maintained until the end of the intervention). A 3-minute warm-up and 2-minute cool-down will be performed at 30% HRR (RPE=9-11). The total duration of MICT, including warm-up and cool-down, will be 35 minutes.
Behavioral: 12 weeks of Moderate-Intensity Continuous Training
Cardiovascular exercise
Cardiovascular exercise
Cortico-spinal excitability
Single pulse of transcranial magnetic stimulation protocol.
Time frame: 12 weeks
Intra-cortical inhibition
Paired-pulse of transcranial magnetic stimulation protocol.
Time frame: 12 weeks
Intra-cortical facilitation
Paired-pulse of transcranial magnetic stimulation protocol.
Time frame: 12 weeks
Systolic resting blood pressure
Supine resting blood pressure.
Time frame: 12 weeks
Diastolic resting blood pressure
Supine resting blood pressure.
Time frame: 12 weeks
Arterial stiffness
Central pulse wave velocity.
Time frame: 12 weeks
Cardiorespiratory fitness
Maximum rate of oxygen consumption measured during maximum physical effort.
Time frame: 12 weeks
Waist-hip ratio
Ratio of waist circumference measured at the level of the umbilicus, and hip circumference taken at the level of the greater trochanters.
Time frame: 12 weeks
Enjoyment
The Physical Activity Enjoyment Scale. Each item is scored 1-7 (1=does not make me happy, 7=makes me happy), yielding a total between 8 and 56.
Time frame: 12 weeks
Motivation
The Behavioral Regulation Exercise Questionnaire-3. 24 items using a 5-point Likert scale (0=Not true for me, 4=Very true for me).
Time frame: 12 weeks
Gait speed
self- and fast-paced 6-meter gait speed.
Time frame: 12 weeks
Walking capacity
6-Minute Walk Test.
Time frame: 12 weeks
Motor learning
A motor task that requires modulating hand-grasping force. The goal is to apply force, move the cursor, and reach targets displayed on the screen as accurately as possible.
Time frame: 12 weeks
Plan to share: No — Results will be publish in peer-review journals.
Started Jan 2020 (actual). Primary completion is estimated for Sep 2024, 56 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 56 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.